{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:55:06Z","timestamp":1776322506896,"version":"3.50.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015542","name":"GlaxoSmithKline Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015542","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,3,3]]},"DOI":"10.1080\/14796694.2025.2460419","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T04:21:51Z","timestamp":1738642911000},"page":"681-690","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Treatment landscape and disease burden of patients with multiple myeloma in Japan: a real-world survey"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1853-974X","authenticated-orcid":false,"given":"Yusuke","family":"Yasutomi","sequence":"first","affiliation":[{"name":"GSK","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-8737","authenticated-orcid":false,"given":"Amanda","family":"Ribbands","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-3635","authenticated-orcid":false,"given":"Emily","family":"Luke","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"McNamara","sequence":"additional","affiliation":[{"name":"GSK, Stevenage","place":["Hertfordshire, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02636-8"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx096"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0846"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.127860"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06979-7"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.138"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0841-y"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_4028_20"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00560-x"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1686870"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285947"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010105"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.79"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02096"},{"key":"#cr-split#-e_1_3_8_17_1.1","unstructured":"JSH practical guidelines for hematological malignancies 2024: version 3.1. iii. Myeloma"},{"key":"#cr-split#-e_1_3_8_17_1.2","unstructured":"1. Multiple myeloma (mm). 2024 [cited 2025 Jan 15]. Available from: http:\/\/www.jshem.or.jp\/gui-hemali\/3_1_1.html"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-568923"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30020179"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00695-5"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.01.011"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2279679"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S120101"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802457040"},{"key":"e_1_3_8_27_1","unstructured":"EQ-5D-5L [Internet]. Rotterdam The Netherlands: EuroQol; 2024 May 28. Available from: https:\/\/euroqol.org\/information-and-support\/euroqol-instruments\/eq-5d-5l\/"},{"key":"e_1_3_8_28_1","unstructured":"EORTC QLQ-C30 Scoring Manual [Internet]. Brussels Belgium: EORTC; 2001 [2024 May 28]. Available from: https:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.04.022"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01206.x"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631200"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyab178"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.03.010"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07836-x"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0020"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283931"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.05.228"},{"key":"e_1_3_8_39_1","unstructured":"Genmab announces approval of DARZALEX(R) (daratumumab) in frontline multiple myeloma in Japan [internet]. Copenhagen Denmark: Genmab; 2019 [cited May 28]. Available from: https:\/\/ir.genmab.com\/news-releases\/news-release-details\/genmab-announces-approval-darzalexr-daratumumab-frontline"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000444"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1800451"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2140284"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2018_170519N363"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19627"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08881-7"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072160"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0435-7"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2460419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:52:51Z","timestamp":1769586771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2460419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3,3]]}},"alternative-id":["10.1080\/14796694.2025.2460419"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2460419","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}